Is Varonis profitable?
Financial reports and public earnings filings for Varonis Systems show that the company navigates a strategic scaling phase typical of high-growth enterprise software firms, balancing substantial ongoing investments in research, development, and cloud platform expansion against growing subscription revenues. While quarterly net income results fluctuate as it completes its transition to a cloud-based software model, its strong annual recurring revenue growth and enterprise customer retention reflect solid underlying business scale.
Related FAQs
Varonis maintains deep foundational and operational roots in Israel, having been originally established in Herzliya, Israel, where its primary research and development engineering centers are located.
There is no record of a company specifically named "VBL Therapeutics" executing a recent stock split in the manner suggested.
Israel is globally renowned as a powerhouse for cybersecurity innovation, hosting numerous major multinational research centers and homegrown defense technology enterprises.
Equity research analysts tracking Varonis Systems (NASDAQ: VRNS) frequently evaluate its investment potential based on its ongoing transition toward a high-margin software-as-a-service subscription business model and rising annual recurring revenue m...
Varonis Systems is a prominent leader in data security and unstructured data access governance, facing competition from various cloud-native data security posture management and enterprise data protection platforms.
Veracyte, Inc. (VRNS) operates as a specialized genomic diagnostics company focusing on advanced cancer testing solutions that improve clinical decision-making and precision medicine.
Determining whether Cyera is "better" than Varonis depends entirely on your specific organizational needs, as both companies provide solutions in the Data Loss Prevention (DLP) and Data Security Posture Management (DSPM) categories.
Varonis Systems, Inc. (traded under the ticker symbol VRNS on the NASDAQ exchange) maintains a dividend yield of 0.00%, as the enterprise does not distribute regular cash dividends to its common shareholders.
Varonis Systems provides an advanced data security and insider risk management platform utilized by thousands of global enterprises, financial institutions, healthcare systems, and retail corporations to protect sensitive unstructured data.
Varonis Systems operates entirely as an enterprise cybersecurity and software development firm specializing in data security posture management, compliance automation, and insider threat detection.
Vaxcyte does not distribute cash dividend payments to its common equity shareholders.
Varonis Systems specializes in enterprise data security and insider threat detection software, empowering organizations to map, secure, and manage their sensitive unstructured and structured data stores across cloud-based and on-premises environments...
Corporate entities, variable rate financial notes, or specialized securities designated under the VRN ticker look toward dynamic future trajectories shaped by shifting global interest rate benchmarks, monetary policy cycles, and credit market conditi...
The corporate brand name Varonis is a modern trade name and linguistic creation established by Varonis Systems, a prominent American software enterprise specializing in data security and cyber resilience.
Customer reviews for the Varonis Data Security Platform are overwhelmingly positive, averaging around 4.6 out of 5 stars across independent software review platforms.
Wall Street equity research analysts tracking Varonis Systems evaluate its investment potential based on its ongoing business model transition toward a cloud-first software-as-a-service subscription structure.